Last10K.com

Anixa Biosciences Inc (ANIX) SEC Filing 10-Q Quarterly Report for the period ending Friday, April 30, 2021

Anixa Biosciences Inc

CIK: 715446 Ticker: ANIX
Document and Entity Information - shares
6 Months Ended
Apr. 30, 2021
Jun. 10, 2021
Cover [Abstract]  
Entity Registrant NameAnixa Biosciences Inc 
Entity Central Index Key0000715446 
Document Type10-Q 
Document Period End DateApr. 30, 2021 
Amendment Flagfalse 
Current Fiscal Year End Date--10-31 
Entity Current Reporting StatusYes 
Entity Interactive Data CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Business Flagtrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 29,949,905
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2021 

View differences made from one quarter to another to evaluate Anixa Biosciences Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Anixa Biosciences Inc.

Continue

Assess how Anixa Biosciences Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Anixa Biosciences Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Financial
Revenue
Legal
Other
Filter by Subcategory:
All
Expense
Product
Shares
Cash Flow
Income
Other
Inside Anixa Biosciences Inc's 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited)
Condensed Consolidated Statements Of Operations (Unaudited) (Parenthetical)
Condensed Consolidated Statements Of Shareholders' Equity (Unaudited)
Condensed Consolidated Statements Of Shareholders' Equity (Unaudited) (Parenthetical)
Accrued Expenses
Accrued Expenses (Tables)
Accrued Expenses - Schedule Of Accrued Expenses (Details)
Business And Funding
Business And Funding (Details Narrative)
Business And Funding (Tables)
Business And Funding - Schedule Of Changes In Noncontrolling Interest (Details)
Commitments And Contingencies
Effect Of Recently Adopted And Issued Pronouncements
Fair Value Measurements
Fair Value Measurements (Tables)
Fair Value Measurements - Schedule Of Fair Value Measurements (Details)
Income Taxes
Income Taxes (Details Narrative)
Leases
Leases (Details Narrative)
Leases (Tables)
Leases - Schedule Of Minimum Lease Payments (Details)
Leases - Schedule Of Operating Lease (Details)
Net Loss Per Share Of Common Stock
Net Loss Per Share Of Common Stock (Details Narrative)
Public Offering
Public Offering (Details Narrative)
Segment Information
Segment Information (Details Narrative)
Segment Information (Tables)
Segment Information - Schedule Of Segment Information (Details)
Stock Based Compensation
Stock Based Compensation (Details Narrative)
Stock Based Compensation (Tables)
Stock Based Compensation - Schedule Of Option Activity (Details)
Stock Based Compensation - Schedule Of Outstanding And Exercisable (Details)
Ticker: ANIX
CIK: 715446
Form Type: 10-Q Quarterly Report
Accession Number: 0001493152-21-014032
Submitted to the SEC: Thu Jun 10 2021 4:30:49 PM EST
Accepted by the SEC: Thu Jun 10 2021
Period: Friday, April 30, 2021
Industry: Medical Laboratories

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/anix/0001493152-21-014032.htm